CHK1 inhibition as a therapeutic approach in KRAS mutated and squamous cell carcinoma NSCLC patients.

被引：1
|
作者：
Morales-Espinosa, Daniela
Garcia-Roman, Silvia
Molina-Vila, Miguel Angel
Capitan, Ana Gimenez
Bertran-Alamillo, Jordi
Mendez, Pedro
Ramirez, Santiago Viteri
Karachaliou, Niki
Rosell, Rafael
机构：
[1] Quiron Dexeus Univ Hosp, Inst Oncol Dr Rosell, Translat Res Lab, Barcelona, Spain
[2] Pangaea Biotech, Barcelona, Spain
[3] Quiron Dexeus Univ Hosp, Lab Oncol, Pangaea Biotech, Barcelona, Spain
[4] Lab Translat Oncol, Pangaea Biotech, Barcelona, Spain
[5] UCSF Helen Diller Family Comprehens Canc Ctr, Thorac Oncol Lab, San Francisco, CA USA
[6] Quiron Dexeus Univ Inst, Translat Res Unit, Barcelona, Spain
[7] Quiron Dexeus Univ Inst, Med Oncol Serv, Barcelona, Spain
[8] Quiron Dexeus Univ Inst, Inst Oncol Dr Rosell IOR, Translat Res Unit, Barcelona, Spain
[9] Catalan Inst Oncol, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.11581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11581
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Chk1 inhibition: a promising targeted treatment for head and neck squamous cell carcinoma
    van Harten, Anne M.
    Stigter-van Walsum, Marijke
    Buijze, Marijke
    Braakhuis, Boudewijn Jm
    Brakenhoff, Ruud H.
    CANCER RESEARCH, 2016, 76
  • [2] Inhibition of Chk1 and Wee1 as a new therapeutic approach in Mantle Cell Lymphoma
    Carrassa, Laura
    Chila, Rosaria
    Basana, Alessandra
    Ricci, Francesca
    Guffanti, Federica
    Lupi, Monica
    Rinaldi, Andrea
    Cascione, Luciano
    Bertoni, Francesco
    Broggini, Massimo
    Damia, Giovanna
    CANCER RESEARCH, 2014, 74 (19)
  • [3] ING2 loss sensitizes KRAS-mutated NSCLC to WEE1 inhibition through regulation of CHK1 expression.
    Ricordel, Charles
    Thalappilly, Subash
    Archambeau, Jerome
    Chan, Angela
    Nixon, Nancy
    Desrues, Benoit
    Bebb, Gwyn
    Riabowol, Karl
    Pedeux, Remy
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 57 - 57
  • [4] Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro
    Wang, Zhihui
    Forsund, Mette S.
    Trope, Claes G.
    Nesland, Jahn M.
    Holm, Ruth
    Slipicevic, Ana
    CANCER MEDICINE, 2018, 7 (08): : 3955 - 3964
  • [5] Positive effects of PARP-1 inhibition in KRAS-mutated intrahepatic cholangiocarcinoma is mediated by CHK1 kinase
    Castven, Darko
    Keggenhoff, Friederike
    Stojkovic, Stojan
    Becker, Diana
    Castven, Jovana
    Zimpel, Carolin
    Straub, Beate
    Langer, Harald
    Hahnel, Patrizia
    Kindler, Thomas
    Fahrer, Jörg
    Rourke, Colm O.
    Ma, Lichun
    Wang, Xin W.
    Gaiser, Timo
    Matter, Matthias
    Sina, Christian
    Derer, Stefanie
    Roessler, Stephanie
    Kaina, Bernd
    Andersen, Jesper
    Galle, Peter
    Marquardt, Jens
    JOURNAL OF HEPATOLOGY, 2023, 78 : S536 - S537
  • [6] Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
    M Bartucci
    S Svensson
    P Romania
    R Dattilo
    M Patrizii
    M Signore
    S Navarra
    F Lotti
    M Biffoni
    E Pilozzi
    E Duranti
    S Martinelli
    C Rinaldo
    A Zeuner
    M Maugeri-Saccà
    A Eramo
    R De Maria
    Cell Death & Differentiation, 2012, 19 : 768 - 778
  • [7] Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
    Bartucci, M.
    Svensson, S.
    Romania, P.
    Dattilo, R.
    Patrizii, M.
    Signore, M.
    Navarra, S.
    Lotti, F.
    Biffoni, M.
    Pilozzi, E.
    Duranti, E.
    Martinelli, S.
    Rinaldo, C.
    Zeuner, A.
    Maugeri-Sacca, M.
    Eramo, A.
    De Maria, R.
    CELL DEATH AND DIFFERENTIATION, 2012, 19 (05): : 768 - 778
  • [8] Radiosensitization of HPV Positive Head and Neck Squamous Cell Carcinomas (HNSCC) by Chk1 Inhibition
    Busch, C-J
    Kriegs, M.
    Laban, S.
    Tribius, S.
    Knecht, R.
    Petersen, C.
    Dikomey, E.
    Rieckmann, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 78 - 79
  • [9] Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation
    Restelli, Valentina
    Vagni, Micaela
    Arribas, Alberto J.
    Bertoni, Francesco
    Damia, Giovanna
    Carrassa, Laura
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 129 - 133
  • [10] Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances In Vitro and In Vivo Cytotoxicity in Head and Neck Squamous Cell Carcinoma
    Zeng, Ling
    Beggs, Reena R.
    Cooper, Tiffiny S.
    Weaver, Alice N.
    Yang, Eddy S.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (04) : 591 - 600
12345